EX-23.1 3 nt10017732x3_ex23-1.htm EXHIBIT 23.1
Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the Registration Statement of Rocket Pharmaceuticals, Inc. on Form S-3 to be filed on or about December 9, 2020 of our report dated March 6, 2020 on our audit of the consolidated financial statements as of December 31, 2019 and 2018 and for the years then ended, which report was included in the Annual Report on Form 10-K filed on March 6, 2020.  Our report includes an explanatory paragraph that refers to a change in the method of accounting for leases due to the adoption of Accounting Standards Update 2016-02, Leases.

/s/ EisnerAmper LLP

EISNERAMPER LLP
Philadelphia, Pennsylvania
December 9, 2020